computerized neuropsychological screening test battery neurocog fx (NeuroCog Trials)
90
Structured Review
NeuroCog Trials
computerized neuropsychological screening test battery neurocog fx
Computerized Neuropsychological Screening Test Battery Neurocog Fx, supplied by NeuroCog Trials, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computerized+neuropsychological+screening+test+battery+neurocog+fx/computer+based+test+battery+neurocog+fx/pm23736996-21-40-58
Average 90 stars, based on 1 article reviews
Computerized Neuropsychological Screening Test Battery Neurocog Fx, supplied by NeuroCog Trials, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computerized+neuropsychological+screening+test+battery+neurocog+fx/computer+based+test+battery+neurocog+fx/pm23736996-21-40-58
Average 90 stars, based on 1 article reviews
computerized neuropsychological screening test battery neurocog fx - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Battery:Article Title: Progressive cognitive dysfunction in spinocerebellar ataxia type 3. Article Snippet: Background: Although it is well established that there is cognitive dysfunction in spinocerebellar ataxia type 3 (SCA3), it is unknown whether cognition deteriorates with disease progression.. We therefore prospectively studied cognitive function in patients with SCA3.. Methods: Eleven patients with SCA3 were assessed using an extensive neuropsychological test battery and retested after 3.5 6 0.4 years. Sequencing:Article Title: Progressive cognitive dysfunction in spinocerebellar ataxia type 3. Article Snippet: Background: Although it is well established that there is cognitive dysfunction in spinocerebellar ataxia type 3 (SCA3), it is unknown whether cognition deteriorates with disease progression.. We therefore prospectively studied cognitive function in patients with SCA3.. Methods: Eleven patients with SCA3 were assessed using an extensive neuropsychological test battery and retested after 3.5 6 0.4 years. |